Isolated cardiac sarcoidosis: A focused review of an under-recognized entity (vol 25, pg 1136, 2018)

被引：0

作者：

Okada, David R. ^{[1
]}

Bravo, Paco E. ^{[2
]}

Vita, Tomas ^{[3
]}

Agarwal, Vikram ^{[3
]}

Osborne, Michael T. ^{[4
]}

Taqueti, Viviany R. ^{[2
]}

Skali, Hicham ^{[2
]}

Chareonthaitawee, Panithaya ^{[5
]}

Dorbala, Sharmila ^{[2
,3
]}

Stewart, Garrick ^{[2
]}

Di Carli, Marcelo ^{[2
,3
]}

Blankstein, Ron ^{[2
,3
]}

机构：

[1] Johns Hopkins Univ Hosp, Dept Med, Div Cardiol, Baltimore, MD 21287 USA

[2] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA

[4] Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02114 USA

[5] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA

来源：

JOURNAL OF NUCLEAR CARDIOLOGY | 2018年 / 25卷 / 04期

关键词：

cardiac MRI; cardiac PET; Cardiac sarcoidosis;

D O I：

10.1007/s12350-016-0688-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is accumulating evidence for the existence of a phenotype of isolated cardiac sarcoidosis (ICS), or sarcoidosis that only involves the heart. In the absence of biopsy-confirmed cardiac sarcoidosis (CS), existing diagnostic criteria require the presence of extra-cardiac sarcoidosis as an inclusion criterion for the diagnosis of CS. Consequently, in the absence of a positive endomyocardial biopsy, ICS is not diagnosable by current guidelines. Therefore, there is uncertainty regarding the epidemiology, pathobiology, clinical characteristics, prognosis, and optimal treatment of ICS. This review will summarize the available data related to the prevalence and prognosis of ICS and will discuss challenges surrounding the diagnosis and management of this under-recognized entity.

引用

页码：1147 / 1147

页数：1